Follistatin 315
Follistatin Isoform 315 (FST-315)
Evidence & Status
- Preliminary / Experimental
- Preliminary
At a Glance
The mature circulating follistatin isoform, distinct from FST344 gene-transfer constructs.
Plain English
FST315 identity must not be conflated with FST344 gene-transfer research.
Overview
FST315 is the mature circulating follistatin isoform. The FST gene encodes a 344-amino-acid precursor; processing yields mature FST315. FST288 arises through alternative splicing, lacks the 27-amino-acid C-terminal sequence present in FST315, and is more heparan/cell-surface associated, while FST315 is more circulating.
Research Summary
Identity and isoform sources support FST315/FST288 biology. NCT01519349 and NCT02354781 concern FST344 gene transfer and must not be used as evidence for direct FST315 protein administration, pharmacokinetics, dosing, efficacy, or safety.
Research Areas
- Muscle hypertrophy
- Myostatin and activin inhibition
- Reproductive biology
- Bone density
- Fibrosis
Legal Status by Region
- United States
- Research only
- United Kingdom
- Research only
- Australia
- Research only
- Canada
- Research only
Citations & Sources
- Recombinant expression of human follistatin with 315 and 288 amino acids: chemical and biological comparison with native porcine follistatin
Endocrinology · 1991
PMID 1906804 · DOI 10.1210/endo-129-2-815
- Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions
Journal of Biological Chemistry · 2007
PMID 17409095 · DOI 10.1074/jbc.M700737200
- Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis
Registry NCT01519349
- Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy
Registry NCT02354781